Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs Comparator in Complicated Urinary Tract Infection or Pyelonephritis
NCT00229021Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of doripenem in complicated urinary tract infection (cUTI) and pyelonephritis (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Microbiological response measured at test of cure visit. Started Dec 2003; status: completed.
02
Drugs
doripenem
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT00229021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229021.